Notícias

Coronavirus disease 2019 (COVID-19) has caused significant devastation globally. Despite the development of several vaccines, with uncertainty around global uptake...

BNT162b2, a nucleoside-modified mRNA formulated in lipid nanoparticles that encodes the SARS-CoV-2 spike glycoprotein (S) stabilized in its prefusion conformation,...

In a randomized clinical trial of 86 hospitalized COVID-19 patients comparing standard care to treatment with 300mL convalescent plasma containing...

Until very recently, vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) had not been authorized for emergency use in...

Favipiravir possesses high utility for treating patients with COVID-19. However, research examining the efficacy and safety of favipiravir for patients...

Among the therapies against the pandemic SARS-CoV-2 virus, monoclonal Antibodies (mAbs) targeting the Spike glycoprotein represent good candidates to interfere...

Coronavirus disease 2019 (COVID-19) is a fatal respiratory illness caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The identification...

The novel coronavirus outbreak began in late December 2019 and rapidly spread worldwide, critically impacting public health systems. A number...

ABIFINA participa do “Fórum de Saúde Brasil”, organizado pelo jornal O Globo, que
debateu “A falta de insumos e...

ABIFINA participa de audiência pública sobre desenvolvimento da cadeia nacional de
saúde e faz alerta sobre proposta de alteração...

GT-Farma criado pelo Ministério da Ciência, Tecnologia e Inovações (MCTI) divulga
balanço das ações realizadas. A ABIFINA integra este...

GT-Farma apresenta balanço de ações ao ministro Marcos Pontes. Criado para
desenvolver insumos farmacêuticos e medicamentos no Brasil, GT...